Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis
Zhenglei Shen(Kunming Medical University), Yunchao Huang(North China University of Water Resources and Electric Power), Xuezhong Gu(First People's Hospital of Yunnan Province), Zhe Zhang(Children's Hospital of Philadelphia), Ling Yang(Kunming Medical University), Wenwen Mao, Lilan Wang(Kunming Medical University), Liefen Yin(Kunming Medical University), Kunmei Liu(Kunming Medical University)
Cited by 73
Related Papers
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Best Linear Unbiased Prediction of Genomic Breeding Values Using a Trait-Specific Marker-Derived Relationship Matrix
|PLoS ONE|2010|252